Zoetis | ZTS - Ebitda

Stock Price
74.22
Daily Change
-1.26 -1.67%
Monthly
-37.65%
Yearly
-54.48%
Q2 Forecast
72.73

Zoetis reported $939M in EBITDA for its fiscal quarter ending in December of 2025.





Ebitda Change Date
AbbVie USD 5.37B 1.85B Dec/2025
Align Technology USD 260.87M 77.03M Dec/2025
Bayer EUR 4.45B 2.49B Mar/2026
Bristol-Myers Squibb USD 2.88B 1.36B Dec/2025
Charles River Laboratories USD 229.8M 28.26M Mar/2026
Coherus Biosciences USD -43.33M 4.7M Sep/2025
Dentsply International USD 129M 6M Mar/2026
Eli Lilly USD 12.14B 4.26B Dec/2025
Henry Schein USD 289M 2M Mar/2026
Idexx Laboratories USD 400.87M 45.95M Mar/2026
Illumina USD 469M 137M Dec/2025
IQVIA Holdings USD 932M 114M Mar/2026
J&J USD 7.19B 2.32B Dec/2025
Laboratory Of America USD 605.6M 17.5M Mar/2026
Merck USD 6.3B 2.09B Dec/2025
Neogen USD 48.2M 546K Dec/2025
Pacira USD 40.24M 1.53M Mar/2026
Perrigo USD 141.6M 1.34B Mar/2026
Pfizer USD 5.99B 5.23B Mar/2026
Phibro Animal Health USD 68.1M 6.2M Dec/2025
Quest Diagnostics USD 557M 20M Mar/2026
Sanofi EUR 3.31B 3.65B Mar/2026
Sanofi EUR 5.66B 3.77B Sep/2025
Zoetis USD 939M 101M Dec/2025